About | Free Trial

Last Update

2016-04-05T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Chrystal Menard?

Ms. Chrystal Menard N.

Chief Legal Officer and General Counsel

Cerus Corporation

Direct Phone: (925) ***-****       

Email: c***@***.com

Cerus Corporation

2550 Stanwell Drive Ste 300

Concord, California 94520

United States

Company Description

Cerus Corporation, is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. T ... more

Find other employees at this company (289)

Background Information

Employment History

Chief Legal Officer
UnitedHealth Group....Cerus Corp.

Partner
Cooley LLP

Senior Corporate Counsel
ZYNGA INC

Education

Bachelor of Science
finance and accounting
University of Colorado , Boulder

Juris Doctorate

University of Chicago

Web References (24 Total References)


Cerus - Management Team

www.cerus.com, $reference.date [cached]

- Chrystal Menard - Chief Legal Officer

...
Chrystal Menard Chief Legal Officer
...
Ms. Menard was appointed Chief Legal Officer in 2012. Prior to joining Cerus, Ms. Menard served as senior corporate counsel at Zynga, Inc. From 2000-2011, she was a partner at Cooley LLP, where she had practiced corporate and securities law. Ms. Menard received her Juris Doctorate from the University of Chicago and her Bachelor of Science in finance and accounting from the University of Colorado, Boulder.


Cerus - Management Team

www.cerus.com, $reference.date [cached]

William 'Obi' M. Greenman | Richard J. Benjamin MBChB, PhD, FRCPath | Laurence M. Corash, M.D. | Kevin D. Green | Caspar Hogeboom | Suzanne Margerum | Chrystal Menard | Carol Moore | Nina Mufti | Lori L. Roll | Adonis Stassinopoulos | Kenneth Trader

...
- Chrystal Menard - Chief Legal Officer
...
Chrystal Menard Chief Legal Officer
...
Ms. Menard was appointed Chief Legal Officer in 2012. Prior to joining Cerus, Ms. Menard served as senior corporate counsel at Zynga, Inc. From 2000-2011, she was a partner at Cooley LLP, where she had practiced corporate and securities law. Ms. Menard received her Juris Doctorate from the University of Chicago and her Bachelor of Science in finance and accounting from the University of Colorado, Boulder.


Cerus - Investors - Press Releases

www.cerus.com, $reference.date [cached]

10/25/2012 Cerus Appoints Chrystal Menard as Chief Legal Officer 10/16/2012 Cerus to Release Third Quarter Results on October 30, 2012 09/11/2012 Cerus to Partner with American Red Cross and Blood Systems Incorporated to Commercialize INTERCEPT Plasma for Thrombotic Thrombocytopenic Purpura (TTP) Orphan Indication 08/30/2012 Cerus to Present at the Baird Healthcare Conference on September 6, 2012 08/29/2012 Cerus to Present at the Stifel Nicolaus Weisel Healthcare Conference on September 5, 2012 08/08/2012 Cerus to Present at the Wedbush 2012 Life Sciences Management Access Conference on August 14 08/07/2012 Cerus Announces First INTERCEPT Blood System Customer in Turkey 08/02/2012 Cerus Corporation Reports Second Quarter 2012 Results 07/19/2012 Cerus to Release Second Quarter 2012 Results on August 2, 2012 05/01/2012 Cerus Corporation Reports First Quarter 2012 Results 04/30/2012 Cerus, the University Hospitals of Geneva, and the Transfusion Service of the Swiss Red Cross Intend to Collaborate on Whole Blood Pathogen Inactivation for Africa 04/24/2012 Cerus and New York Blood Center to Collaborate on Development of Novel Red Blood Cell Biologic Product with Improved Uniformity 04/18/2012 Cerus Announces First INTERCEPT Platelet System Customer in Austria 04/12/2012 Cerus to Release First Quarter 2012 Results on May 1, 2012 04/03/2012 Cerus Announces New Supply Agreement with Largest Blood Service in Saudi Arabia 03/21/2012 Cerus Submits Investigational Device Exemption (IDE) Supplement to FDA for Phase III INTERCEPT Red Blood Cell Study 02/29/2012 Cerus to Present at the Cowen and Company 32nd Annual Healthcare Conference on March 7, 2012 02/28/2012 Cerus Corporation Reports Fourth Quarter and Year-End 2011 Results 02/06/2012 Cerus to Present at the 14th Annual BIO CEO & Investor Conference on February 13, 2012 02/02/2012 Cerus to Release Fourth Quarter and Year-End 2011 Results on February 28, 2012


10/25/2012 Cerus Appoints ...

www.cerus.com, $reference.date [cached]

10/25/2012 Cerus Appoints Chrystal Menard as Chief Legal Officer 10/16/2012 Cerus to Release Third Quarter Results on October 30, 2012 09/11/2012 Cerus to Partner with American Red Cross and Blood Systems Incorporated to Commercialize INTERCEPT Plasma for Thrombotic Thrombocytopenic Purpura (TTP) Orphan Indication 08/30/2012 Cerus to Present at the Baird Healthcare Conference on September 6, 2012 08/29/2012 Cerus to Present at the Stifel Nicolaus Weisel Healthcare Conference on September 5, 2012 08/08/2012 Cerus to Present at the Wedbush 2012 Life Sciences Management Access Conference on August 14 08/07/2012 Cerus Announces First INTERCEPT Blood System Customer in Turkey 08/02/2012 Cerus Corporation Reports Second Quarter 2012 Results 07/19/2012 Cerus to Release Second Quarter 2012 Results on August 2, 2012 05/01/2012 Cerus Corporation Reports First Quarter 2012 Results 04/30/2012 Cerus, the University Hospitals of Geneva, and the Transfusion Service of the Swiss Red Cross Intend to Collaborate on Whole Blood Pathogen Inactivation for Africa 04/24/2012 Cerus and New York Blood Center to Collaborate on Development of Novel Red Blood Cell Biologic Product with Improved Uniformity 04/18/2012 Cerus Announces First INTERCEPT Platelet System Customer in Austria 04/12/2012 Cerus to Release First Quarter 2012 Results on May 1, 2012 04/03/2012 Cerus Announces New Supply Agreement with Largest Blood Service in Saudi Arabia 03/21/2012 Cerus Submits Investigational Device Exemption (IDE) Supplement to FDA for Phase III INTERCEPT Red Blood Cell Study 02/29/2012 Cerus to Present at the Cowen and Company 32nd Annual Healthcare Conference on March 7, 2012 02/28/2012 Cerus Corporation Reports Fourth Quarter and Year-End 2011 Results 02/06/2012 Cerus to Present at the 14th Annual BIO CEO & Investor Conference on February 13, 2012 02/02/2012 Cerus to Release Fourth Quarter and Year-End 2011 Results on February 28, 2012


Chrystal N. ...

www.sec.gov, $reference.date [cached]

Chrystal N. Menard

...
Chrystal N. Menard was appointed our Chief Legal Officer in December 2012. From August 2011 until October 2012, Ms. Menard was Senior Corporate Counsel at Zynga Inc. Prior to August 2011, Ms. Menard was a partner of the law firm presently named Cooley LLP, practicing corporate and securities law.

Similar Profiles

Other People with this Name (6,670)

Other people with the name Menard

Neil Menard
Merritt Herald

Stéphanie Ménard
Les amis de la montagne

Anne Menard
TD Assurance

Pierre Menard
Department of Social Services

Madeleine Ménard
ExpertFile Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory